Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Science

• Publication date

  1982-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.6181563PMID 6181563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenesis and prediction of sarcoma formation by plastic.

  1981cited by this paper
• Angiogenesis as a marker of preneoplastic lesions of the human breast

  1978cited by this paper
• Angiogenesis and oncogenesis.

  1978cited by this paper
• Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia.

  1977cited by this paper
• Natural history of breast cancer: Progression from hyperplasia to neoplasia as predicted by angiogenesis

  1977cited by this paper
• Neovascularization induced by intraocular xenografts of normal, preneoplastic, and neoplastic mouse mammary tissues.

  1976cited by this paper
• Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse.

  1976cited by this paper
• Letter: Breast lobules.

  1976cited by this paper
• Preneoplastic lesions in the human breast.

  1976cited by this paper
• Letter: Erythrocyte sedimentation rates and malignancy: role of age and erythrocyte aggregation.

  1976cited by this paper
• An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

  1975cited by this paper
• Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors.

  1973cited by this paper
• On the origin and progression of ductal carcinoma in the human breast.

  1973cited by this paper
• TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATION

  1972cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper
• Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

  1959cited by this paper
• The role of graft and host vessels in the vascularization of grafts of normal and neoplastic tissue.

  1956cited by this paper
• HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS

  1941cited by this paper
• HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS I. THE TRANSFER OF RABBIT TUMORS TO ALIEN SPECIES

  1941cited by this paper

• Signaling pathways and targeted interventions for precancers

  2026cites this paper
• The role of pro- and antiangiogenic factors in angiogenesis process by Raman spectroscopy

  2021cites this paper
• Meme kanseri hücre hatlarında propranolol ve paklitakselin anjiyogenez üzerine etkisi

  2019cites this paper
• Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell Analysis.

  2019cites this paper
• Chamaejasmine B Induces the Anergy of Vascular Endothelial Cells to VEGFA Pro-angiogenic Signal by Autophagic Regulation of VEGFR2 in Breast Cancer

  2018cites this paper
• Activity of αvβ6 Integrin in Oral Leukoplakia

  2018cites this paper
• Angiogenesis - a crucial step in breast cancer growth, progression and dissemination by Raman imaging.

  2018cites this paper
• A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening

  2017cites this paper
• Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.

  2016cites this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cites this paper
• Chalcones incorporated pyrazole ring inhibit proliferation, cell cycle progression, angiogenesis and induce apoptosis of MCF7 cell line.

  2014cites this paper
• Leptin’s Pro-Angiogenic Signature in Breast Cancer

  2013cites this paper
• Crosstalk between HER2 signaling and angiogenesis in breast cancer: molecular basis, clinical applications and challenges

  2013cites this paper
• Prognostic Significance of Microvessel Density in Breast Cancer of Indian Population

  2013cites this paper
• Novel Anti-angiogenic Therapies Using Naturally Occurring and Synthetic Drugs to Combat Progestin-Dependent Breast Cancer

  2013cites this paper
• Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature development.

  2013cites this paper
• Sorafenib in locally advanced or metastatic breast cancer

  2012cites this paper
• Multi-scale photoacoustic tomography and its applications to cancer research

  2012cites this paper
• Nanocarrier-Based Drugs: The Future Promise for Treatment of Breast Cancer

  2012cites this paper
• Docetaxel combined with targeted therapies in metastatic breast cancer.

  2012cites this paper
• Targeting Angiogenesis in Advanced Breast Cancer

  2012cites this paper
• Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials.

  2012cites this paper
• The Role of Vascular Endothelial Growth Factor A Polymorphisms in Breast Cancer

  2012cites this paper
• Inhibition of Breast Tumor Cell Growth by Ectopic Expression of p16/INK4A Via Combined Effects of Cell Cycle Arrest, Senescence and Apoptotic Induction, and Angiogenesis Inhibition

  2012cites this paper
• Molecular MR Contrast Agents for the Detection of Cancer: Past and Present

  2011cites this paper
• Molecular magnetic resonance contrast agents for the detection of cancer: past and present.

  2011cites this paper
• Antitumor activity of NRC-AN-019 in a pre-clinical breast cancer model.

  2011cites this paper
• Antiangiogenic therapy for breast cancer: current status and future perspectives

  2011cites this paper
• vited Revie w Histology and Histopathology Angiogenesis : an update

  2010cites this paper
• Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?

  2010cites this paper
• Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.

  2009cites this paper
• Role of Prolactin and Vasoinhibins in the Regulation of Vascular Function in Mammary Gland

  2008cites this paper
• Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.

  2008cites this paper
• Angiogenesis as a therapeutic target in advanced breast cancer

  2008cites this paper
• Antiangiogenic Agents in Breast Cancer

  2007cites this paper
• Breast magnetic resonance imaging: principles and techniques.

  2007cites this paper
• Breast tumour angiogenesis

  2007cites this paper
• Drug Insight: VEGF as a therapeutic target for breast cancer

  2007cites this paper
• Review Article Vascular Endothelial Growth Factor and Bevacitumab in Breast Cancer

  2007cites this paper
• Tumor-associated carbohydrate antigens.

  2007cites this paper
• [Angiogenesis targeting in breast cancer].

  2007cites this paper
• Vascular endothelial growth factor and bevacitumab in breast cancer

  2007cites this paper
• Lack of Toxicity of Mà © thylà ̈ neBlue Chloride to Supravitally Stained Human Mammary Tissues

  2006influential citation
• Sex-steroid regulation of vascular endothelial growth factor in breast cancer.

  2006cites this paper
• Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer

  2006cites this paper
• Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

  2005cites this paper
• Angiogenesis in Prolactinomas: Regulation and Relationship with Tumour Behaviour

  2005cites this paper
• Angiogenesis of breast cancer.

  2005cites this paper
• Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas.

  2004cites this paper
• The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor.

  2004cites this paper
• Toward Checkmate: Biology and Breast Cancer Therapy for the New Millennium

  2004cites this paper
• Antiangiogenic strategies, compounds, and early clinical results in breast cancer.

  2004cites this paper
• Strain differences and inheritance of angiogenic versus angiostatic activity in oestrogen-induced rat pituitary tumours

  2004cites this paper
• Targeting angiogenesis for mammary cancer prevention: factors to consider in experimental design and analysis.

  2004cites this paper
• Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

  2004cites this paper
• Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma — results of a multiparametric study

  2004cites this paper
• Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis

  2004cites this paper
• Angiogenesis in pituitary adenomas

  2003cites this paper
• Endoglin (CD105) Expression in Endometrial Carcinoma

  2003cites this paper
• Angiogenesis in endocrine tumors.

  2003cites this paper
• Angiogenesis Research: Possible Prognostic and Therapeutic Applications in Breast Cancer

  2002cites this paper
• Breast Microcalcifications Studied with 3d Contrast-enhanced High-field Magnetic Resonance Imaging: More Accuracy in the Diagnosis of Breast Cancer

  2002cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2002cites this paper
• The promise and pitfalls of breast fluid proteins as markers for cancer detection.

  2002cites this paper
• The New Angiotherapy

  2002cites this paper
• Diagnostic and Prognostic Significance of Tumor Angiogenesis

  2002cites this paper
• Ductal Carcinoma In Situ of the Breast: A Comparative Analysis of Histology, Nuclear Area, Ploidy, and Neovascularization Provides Differentiation Between Low‐ and High‐Grade Tumors

  2002cites this paper
• Pregnancy postponement and childlessness leads to chronic hypervascularity of the breasts and cancer risk

  2002cites this paper
• Angiogenesis in Mammary Tumors: Quantitation and Relation to Prognosis

  2001cites this paper
• Different features of angiogenesis between ovarian and breast carcinoma.

  2001cites this paper
• Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non‐small‐cell lung cancer

  2000cites this paper
• DMBA-Induced Mammary Pathologies are Angiogenic In Vivo and In Vitro

  2000cites this paper
• Expression of αvβ6integrin in oral leukoplakia

  2000cites this paper
• Power Doppler angiographic appearance and blood flow velocity waveforms in invasive cervical carcinoma.

  2000cites this paper
• Microvessel quantitation in intraductal and early invasive breast carcinomas.

  2000cites this paper
• Angiogenesis and vasodilation in skin warts. Association with HPV infection.

  2000cites this paper
• Angiogenesis in pituitary adenomas and the normal pituitary gland.

  2000cites this paper
• Contribution of the Extracellular Matrix and Macrophages in Angiogenesis

  1999cites this paper
• Linear motion correction in three dimensions applied to dynamic gadolinium enhanced breast imaging.

  1999cites this paper
• [Angiogenesis in gynecology and obstetrics].

  1999cites this paper
• Local elastic matching and pattern recognition in MR mammography

  1999cites this paper
• Locally Advanced Breast Cancer Treated with Primary Chemotherapy: Comparison between Magnetic Resonance Imaging and Pathologic Evaluation of Residual Disease

  1999cites this paper
• Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer.

  1999cites this paper
• Angiogenesis in malignancies of the female genital tract.

  1999cites this paper
• Angiogenesis in Breast Cancer

  1999cites this paper
• Angiogenesis: possibilities for therapeutic interventions

  1998cites this paper
• Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions--implications for imaging modalities.

  1998cites this paper
• Angiogenic potential of malignant and non‐malignant human breast tissues in an in vivo angiogenesis model

  1998cites this paper
• Cancer du sein (II)

  1998cites this paper
• Cancer du sein (I)

  1998cites this paper
• Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.

  1997cites this paper
• Detection of endothelial cells by MEC 13.3 monoclonal antibody in mice mammary tumors.

  1997cites this paper
• Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.

  1997cites this paper
• Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions.

  1997cites this paper
• Underlying Mechanisms Involved in Surface Electrical Potential Measurements for the Diagnosis of Breast Cancer: An Electrophysiological Approach to Cancer Diagnosis

  1996cites this paper
• Angiogenesis in Preinvasive Lesions of the Breast

  1996cites this paper
• Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts.

  1996cites this paper
• Clinical significance of the determination of angiogenesis in human breast cancer: update of the biological background and overview of the Vicenza studies.

  1996cites this paper
• ANGIOGENESIS IN NORMAL, HYPERPLASTIC, AND NEOPLASTIC ENDOMETRIUM

  1996cites this paper
• Tumor angiogenesis in primary and metastatic colorectal cancers

  1996cites this paper